Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients: a Multicentre, Pragmatic Randomized Trial

NCT05955924 is registered in ClinicalTrials.gov with Women's College Hospital as lead sponsor.

NCT NCT05955924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05955924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients: a Multicentre, Pragmatic Randomized Trial
Lead sponsor
Women's College Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
August 28, 2023
Completion date
August 31, 2027
Enrollment
396 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, basal cell, carcinoma, squamous cell, keratinocyte carcinoma, non-melanoma skin cancer